Latest News
Biostar Pharmaceuticals, Inc. Announces Its Quarte...
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended March 31, 2017 XIANYANG, China, May 19, 2017 /PRNewswire/ - Biostar Pharmaceuticals, In...
 í˙ About Biostar í˙Corporate Overview
Biostar Pharmaceuticals, Inc., through its wholly owned subsidiary and controlled affiliate in China, develops, manufactures and markets pharmaceutical and health supplement products for a variety of diseases and conditions. The Companyí»s most popular product is its Xin Aoxing Oleanolic Acid Capsule, an over-the-counter (í░OTCí▒) medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population.